multidrug-resistant tuberculosis
Lancet Commission report identifies two new modifiable dementia risk factors
The new risk factors identified are untreated vision loss and high low-density lipoprotein
Researchers develop AI blood test to predict Parkinson’s seven years before symptom onset
The neurodegenerative condition currently affects nearly ten million people worldwide
Researchers identify new major cause of inflammatory bowel disease
Crohn’s disease and ulcerative colitis affected more than 500,000 people in the UK in 2022
Two UK clinical trials launched to identify blood tests for dementia diagnosis
The neurodegenerative condition affects more than 944,000 people in the UK
Scientists to develop vaccine to prevent lung cancer following £1.7m grant
Lung cancer is responsible for over 48,000 cases in the UK every year
New technique enables study of immune response to cancer using archived tissue samples
FUME-TCRseq was shown to successfully read formalin-fixed paraffin-embedded tissue samples
Researchers suggest erectile dysfunction drugs could reduce risk of Alzheimer’s
The study found that men prescribed PDE5Is were 18% less likely to develop the disease
Researchers identify five rare cases of Alzheimer’s from historic medical treatments
The study found that c-hGH treatment transmitted the amyloid-beta protein, a hallmark of AD
Levofloxacin revealed as first effective treatment for multi-drug resistant TB
UCL researchers found that levofloxacin prevented MDR-TB by 60%
UCL study finds use of existing drugs improves cervical cancer outcomes
The approach was shown to reduce the risk of death or cancer recurrence by 35%
UCL study finds certain ethnicities experience greater effect of dementia risk factors
Researchers analysed health data from nearly one million adults in England
COVID-19 could be key in identifying viruses with pandemic potential
Researchers analysed major variants of concern, including the Omicron subvariants